Paul Calabresi Clinical Oncology K12 Program FAQs
Appointed scholars are encouraged to apply for individual mentored K awards (e.g., K07, K08, K22, K23) and independent awards (R01, R03, R21); if successfully funded, the Paul Calabresi Clinical Oncology K12 appointment would be terminated.
Mentored K award recipients are encouraged to obtain funding from NIH or other Federal sources either as a PI on a competing research grant award or cooperative agreement, or as project leader on a competing multi-project award. In the first year of their appointment, a Paul Calabresi Clinical Oncology K12 scholar may commit effort but may not receive any other federally-funded salary support. However, in the final two years of their K12 appointment, a scholar may reduce effort on the K award to a minimum of 6 person-months and may hold concurrent support from their K award and a competing PHS research grant on which they are the PD/PI or component lead. To be eligible for salary support from peer-reviewed research awards from any Federal agency: · The K12 scholar must be one of the named PIs on a competing NIH research grant application (R01, R03, R15, R21, R34, or equivalent application from another Federal agency) or a sub-project director on a competing multi-component research or center grant or cooperative agreement application (P01, P50, U01, etc. or an equivalent application from another Federal agency). · The K12 scholar award must be active when the competing research grant application is submitted. · The K12 scholar must be in their final two years before the reduction in effort to 6 person-months (50% full-time professional effort) is permitted.
The following expenses are allowable:
- Research expenses, such as supplies, equipment, and technical personnel.
- Tuition and fees related to required career development courses and activities;
- Travel to scientific meetings or training; and
- Statistical services including personnel and computer time. Costs must be specifically and directly related to the scholar's research activities.
Paul Calabresi Clinical Oncology K12 scholars must hold a junior faculty appointment, as outlined in the Academic Personnel Manual Section 310. “In Progress” appointments are accepted for applicants, but appointments must be finalized prior to the start of the Paul Calabresi Clinical Oncology K12 appointment. Contact the Program Manager prior to submission with questions.
This protected time is for multidisciplinary clinical and translational research with training and mentoring activities.
The scholar’s non-supported effort can be divided among other research, clinical, and teaching activities only if these activities are consistent with the goals of the Paul Calabresi Clinical Oncology K12 program. Divisions/departments must not require extra duties or responsibilities that reduce the scholar’s protected time and interfere with the purpose of the K12 award. An audit may be conducted to ensure compliance.
Yes, this is allowed as long as your paid effort is outside of the 75% KL2-supported effort.
Yes, however, these research projects should all be aligned with your overall research theme, objectives, and specific aims. Since you will need to account for all of your time, you will want to address this in your application.